Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Novaccess Global Inc XSNX

NovAccess Global Inc. is a biopharmaceutical company, which develops immunotherapies to treat brain tumor patients in the United States. The Company specializes in research related to utilizing a patient’s own immune system to attack the cancer. Its dendritic cell-based immunotherapy utilizes a combination of Toll-like receptor adjuvants for an enhanced antitumor response. The therapy is designed to utilize the patient’s tumor antigens and immune cells, dendritic cells, in combination with TLR adjuvants to initiate an efficient antitumor immune response. This process includes obtaining the patients' tumor cells after surgery, and precursors cells that are matured into dendritic cells from peripheral blood. Its TLR-AD1 platform technology is a vaccine immunotherapy for the treatment of aggressive brain cancers, including glioblastoma and other high-grade gliomas. TLR-AD1 technology has a scope of use and is embodied in various different product lines for different clinical situations.


OTCPK:XSNX - Post by User

Bullboard Posts
Post by skyhighon Aug 13, 2007 2:01pm
219 Views
Post# 13237875

More money flowing in to sector

More money flowing in to sectorDJ Analysts See More Money ...Flowing Into Clean-Tech Sector Dow Jones Real-Time News for InvestorsSM 11 24 am 08/08/2007 By Steve Gelsi Deal makers in the so-called clean technology business are mostly brushing aside recent market weakness and forecast a healthy flow of venture capital and other transactions in the solar, biofuel and wind energy sectors for the remainder of the year. "Every area has momentum right now," said Dan Pullman, vice president at investment bank McNamee Lawrence & Co. "You see it solar, you see it wind, alternative transportation, fuels, and plug-in vehicles." Michael Carboy, clean energy analyst at Signal Hill, said the health of the sector has little to do with week-to-week market fluctuations in equity prices. "The appeal of the sector has nothing to do with market valuation - it has everything to do with demand drivers on the national political and economic and global levels," Carboy said. "We have a need to more efficiently use energy, and get more energy from renewable sources. Those don't change based on market valuation. Corrections are an opportunity to look at names thought of as too expensive in the past." Carboy has buy ratings on Sunpower Corp (SPWR) and Suntech Power Holdings Co (STP), and hold ratings on Evergreen Solar Inc (ESLR) and First Solar Inc (FSLR). In the power infrastructure business, Carboy assigned a buy ratings to American Superconductor Corp (AMSC) and Zoltek Cos (ZOLT), a maker of carbon fiber used by wind turbine makers. Carboy sees continued investment by venture capitalists in the sector, especially in energy storage and electric grid efficiency specialists, as well as new solar energy technology. However, he's bearish on the ethanol stocks because they're subject to swings both in corn prices and gasoline prices. "You're playing the spread between the commodity market and the energy market," he said. "It's a dangerous game." Jeffrey Saut, market strategist with Raymond James, sounded a word of caution on solar and other alternative energy shares, however. "If you bet the farm, you better have two farms," Saut said. "Despite what the clean tech people will tell you, if crude oil goes down, the price of anything related to alternative energy comes down with it. Most don't stand on their own feet without high energy prices, or without government tax benefits." Saut also said he likes solar energy long term, is bearish on ethanol, and wonders why free energy from geothermal heat isn't more widely used. Pullman of McNamee Lawrence said obstacles to clean tech include the Bush administration, which plans to veto the recently-passed House Energy Bill as well as the high cost of silicon for solar energy panel makers. Players in the clean-tech market expect more action from Washington - such as carbon trading legislation - after the presidential elections in 2008. On the ethanol front, Pullman sees a pact coming that would allow more sugar cane-based ethanol to be imported into the U.S. from Brazil. Jeff Lipton, managing director of the Clean Tech Group at Jefferies, said investors should approach the sector with some caution in the short term given the summer selloff in the broader market. Looking toward the rest of the year, "I'd expect to see more transactions in terms of IPOs and secondaries," he said. First Solar, for example, just set plans to raise a whopping $1 billion in a stock offering. On the IPO front, GT Solar International Inc. has filed a $200 million initial public offering to boost its business as a maker of manufacturing equipment for the solar power industry. Jefferies is eying new players in the cellulostic ethanol - fuel made from grass and other plant matter, as a more cost-effective source for energy, Lipton said. Venture deals on the clean tech radar screen include a $78 million round for Energy Photovoltaics, a $70 million round for GreenVolts and a $60 million infusion for BullMoose. To boost its presence in the space, Jefferies hired Paul Clegg as senior equity research analyst covering clean-tech companies, including nuclear technology. Clegg most recently worked as a senior equity research analyst at Natexis Bleichroder covering alternative energy, prior to which he covered equity and fixed income securities at Calyon Securities.
Bullboard Posts